Skip to main content
Clinical Trials/NCT05665309
NCT05665309
Not Yet Recruiting
N/A

Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor

Centre Hospitalier Universitaire de Besancon0 sites60 target enrollmentSeptember 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Intracranial Aneurysm
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment
60
Primary Endpoint
Proportion of patients with successful procedure
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This is a preliminary randomised controlled trial comparing the use of pre-operative 3D models to select an intrasaccular flow disruptor for endovascular aneurysm cure.

Detailed Description

Patients will be randomised 3:1 either in the intervention or control group. Intervention consists of using the pre-operative Digital Subtraction Angiography (DSA) to create a 3D plastic model. This model is used to test different sizes of device. At the end of this pre-operative test a single device is recommended for the real procedure. The control group will use the current method for size selection (measurement of mean width and minimum height) on DSA.

Registry
clinicaltrials.gov
Start Date
September 2023
End Date
December 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Intracranial aneurysm, suitable for a treatment by Woven Endobridge (WEB) device after multidisciplinary team decision
  • Consent form signed
  • The patient benefits from health insurance

Exclusion Criteria

  • Legal incapacity
  • Women at risk of pregnancy

Outcomes

Primary Outcomes

Proportion of patients with successful procedure

Time Frame: Day 0

Proportion of patients for which flow disruption succeeded at first intent, without any change of size required for WEB disruptor

Similar Trials